M1 disease was detected with PSMA-PET in 46% of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer.
Black men are "put in disproportionate danger of dying" from prostate cancer due to health inequities and outdated NHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback